{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:27:27Z","timestamp":1792020447728,"version":"4.4.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.tem.2007.11.001","type":"journal-article","created":{"date-parts":[[2008,4,15]],"date-time":"2008-04-15T16:52:44Z","timestamp":1208278364000},"page":"43-49","source":"Crossref","is-referenced-by-count":336,"title":["Copeptin: clinical use of a new biomarker"],"prefix":"10.1016","volume":"19","author":[{"given":"Nils G.","family":"Morgenthaler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Struck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Jochberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin W.","family":"D\u00fcnser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2007.11.001_bib1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2165\/00003495-200363030-00001","article-title":"Management of vasodilatory shock: defining the role of arginine vasopressin","volume":"63","author":"Dunser","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.tem.2007.11.001_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/cc2338","article-title":"Science review: vasopressin and the cardiovascular system part 2 \u2013 clinical physiology","volume":"8","author":"Holmes","year":"2004","journal-title":"Crit. Care"},{"key":"10.1016\/j.tem.2007.11.001_bib3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/cc2337","article-title":"Science review: vasopressin and the cardiovascular system part 1 \u2013 receptor physiology","volume":"7","author":"Holmes","year":"2003","journal-title":"Crit. Care"},{"issue":"Suppl. 1","key":"10.1016\/j.tem.2007.11.001_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000067844","article-title":"Diabetes insipidus","volume":"59","author":"Maghnie","year":"2003","journal-title":"Horm. Res."},{"key":"10.1016\/j.tem.2007.11.001_bib5","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.ajkd.2005.01.008","article-title":"Causes of reversible nephrogenic diabetes insipidus: a systematic review","volume":"45","author":"Garofeanu","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.tem.2007.11.001_bib6","first-page":"24","article-title":"ADH-associated pathologies. Diabetes insipidus and syndrome of inappropriate ADH","volume":"32","author":"Abrams","year":"2000","journal-title":"MLO Med. Lab. Obs."},{"key":"10.1016\/j.tem.2007.11.001_bib7","first-page":"186","article-title":"Inappropriate antidiuretic hormone secretion","volume":"5","author":"Miller","year":"1994","journal-title":"Curr. Ther. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2007.11.001_bib8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/pgmj.75.886.509","article-title":"Drug-induced syndrome of inappropriate antidiuretic hormone secretion","volume":"75","author":"Belton","year":"1999","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.tem.2007.11.001_bib9","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2174\/1381612053764797","article-title":"Non-peptide vasopressin V1b receptor antagonists as potential drugs for the treatment of stress-related disorders","volume":"11","author":"Griebel","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.tem.2007.11.001_bib10","first-page":"320","article-title":"Haemodynamics and fluid retention in liver disease","volume":"30","author":"Henriksen","year":"1998","journal-title":"Ital. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tem.2007.11.001_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/1568007033482850","article-title":"The vasopressin V1b receptor as a therapeutic target in stress-related disorders","volume":"2","author":"Griebel","year":"2003","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.tem.2007.11.001_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0079-6123(02)39017-4","article-title":"Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands","volume":"139","author":"Serradeil-Le Gal","year":"2002","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.tem.2007.11.001_bib13","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/00000542-199210000-00008","article-title":"Stress hormone response during and after cardiopulmonary resuscitation","volume":"77","author":"Lindner","year":"1992","journal-title":"Anesthesiology"},{"key":"10.1016\/j.tem.2007.11.001_bib14","doi-asserted-by":"crossref","first-page":"S432","DOI":"10.1097\/01.CCM.0000134267.91520.C0","article-title":"Vasopressin during cardiopulmonary resuscitation: a progress report","volume":"32","author":"Krismer","year":"2004","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.tem.2007.11.001_bib15","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s00134-004-2283-8","article-title":"Role of vasopressin in the management of septic shock","volume":"30","author":"Mutlu","year":"2004","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.tem.2007.11.001_bib16","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMra002709","article-title":"The pathogenesis of vasodilatory shock","volume":"345","author":"Landry","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2007.11.001_bib17","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/00003246-200301000-00062","article-title":"Patient with a sudden drop in blood pressure","volume":"31","author":"Oliver","year":"2003","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.tem.2007.11.001_bib18","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00003246-200203000-00036","article-title":"Endocrine support in the critically ill","volume":"30","author":"Vincent","year":"2002","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.tem.2007.11.001_bib19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1432-1033.1972.tb01918.x","article-title":"A glycopeptide from the posterior lobe of pig pituitaries. I. Isolation and characterization","volume":"28","author":"Holwerda","year":"1972","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.tem.2007.11.001_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/295299a0","article-title":"Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor","volume":"295","author":"Land","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.tem.2007.11.001_bib21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0002-9149(01)02166-X","article-title":"Usefulness of plasma N-terminal proatrial natriuretic peptide (proANP) as an early predictor of outcome in unstable angina pectoris or non-ST-elevation acute myocardial infarction","volume":"89","author":"Jernberg","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.tem.2007.11.001_bib22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1210\/er.2003-0006","article-title":"Cardiac hormones as diagnostic tools in heart failure","volume":"24","author":"Ruskoaho","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.tem.2007.11.001_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cccn.2003.10.027","article-title":"Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease","volume":"341","author":"Mueller","year":"2004","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.tem.2007.11.001_bib24","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1373\/clinchem.2003.021204","article-title":"Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma","volume":"50","author":"Morgenthaler","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.tem.2007.11.001_bib25","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1186\/cc3015","article-title":"Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study","volume":"9","author":"Morgenthaler","year":"2005","journal-title":"Crit. Care"},{"key":"10.1016\/j.tem.2007.11.001_bib26","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1373\/clinchem.2005.051110","article-title":"Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay","volume":"51","author":"Morgenthaler","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.tem.2007.11.001_bib27","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1016\/j.peptides.2005.05.010","article-title":"Proteolytic processing pattern of the endothelin-1 precursor in vivo","volume":"26","author":"Struck","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.tem.2007.11.001_bib28","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1373\/clinchem.2005.065581","article-title":"Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma","volume":"52","author":"Papassotiriou","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.tem.2007.11.001_bib29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","article-title":"Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin","volume":"52","author":"Morgenthaler","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.tem.2007.11.001_bib30","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1210\/jc.2007-0232","article-title":"Changes in plasma copeptin, the C-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects","volume":"92","author":"Szinnai","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2007.11.001_bib31","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(77)90610-9","article-title":"Plasma-arginine-vasopressin response to insulin-induced hypoglycaemia","volume":"2","author":"Baylis","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.tem.2007.11.001_bib32","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1210\/jcem-53-5-935","article-title":"Arginine vasopressin response to insulin-induced hypoglycemia in man","volume":"53","author":"Baylis","year":"1981","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2007.11.001_bib33","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1210\/jc.2006-2046","article-title":"Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay","volume":"92","author":"Katan","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2007.11.001_bib34","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1210\/jc.2005-2830","article-title":"Copeptin and arginine vasopressin concentrations in critically ill patients","volume":"91","author":"Jochberger","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2007.11.001_bib35","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/0310057X0603400415","article-title":"Course of vasopressin and copeptin plasma concentrations in a patient with severe septic shock","volume":"34","author":"Jochberger","year":"2006","journal-title":"Anaesth. Intensive Care"},{"key":"10.1016\/j.tem.2007.11.001_bib36","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/j.peptides.2005.04.019","article-title":"Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients","volume":"26","author":"Struck","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.tem.2007.11.001_bib37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/SHK.0b013e318033e5da","article-title":"Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock","volume":"28","author":"Morgenthaler","year":"2007","journal-title":"Shock"},{"key":"10.1016\/j.tem.2007.11.001_bib38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00586258","article-title":"The effects of hypotension and hypovolaemia on the liberation of vasopressin during haemorrhage in the unanaesthetized monkey (Macaca mulatta)","volume":"371","author":"Arnauld","year":"1977","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.tem.2007.11.001_bib39","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2362.2006.01724.x","article-title":"Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure","volume":"36","author":"Stoiser","year":"2006","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.tem.2007.11.001_bib40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cardfail.2006.09.004","article-title":"Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and copeptin to predict 1-year mortality in patients with acute destabilized heart failure","volume":"13","author":"Gegenhuber","year":"2007","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.tem.2007.11.001_bib41","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/CIRCULATIONAHA.106.685503","article-title":"C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study","volume":"115","author":"Khan","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.tem.2007.11.001_bib42","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1161\/CIRCULATIONAHA.107.185267","article-title":"National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure","volume":"116","author":"Wilson Tang","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.tem.2007.11.001_bib43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2362.2007.01762.x","article-title":"Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections","volume":"37","author":"Muller","year":"2007","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.tem.2007.11.001_bib44","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1007\/s00134-007-0895-5","article-title":"Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: Results from the German competence network CAPNETZ","volume":"33","author":"Kr\u00fcger","year":"2007","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.tem.2007.11.001_bib45","doi-asserted-by":"crossref","unstructured":"Masia, M. et al. (2007) Midregional proA-type natriuretic peptide and carboxy-terminal provasopressin may predict prognosis in community-acquired pneumonia. Clin. Chem. (in press)","DOI":"10.1373\/clinchem.2007.085688"},{"key":"10.1016\/j.tem.2007.11.001_bib46","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1378\/chest.06-2336","article-title":"Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD","volume":"131","author":"Stolz","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.tem.2007.11.001_bib47","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00003246-200203000-00001","article-title":"Depletion of neurohypophyseal content of vasopressin in septic shock","volume":"30","author":"Sharshar","year":"2002","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.tem.2007.11.001_bib48","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1097\/01.CCM.0000063046.82359.4A","article-title":"Circulating vasopressin levels in septic shock","volume":"31","author":"Sharshar","year":"2003","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.tem.2007.11.001_bib49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0885066602239119","article-title":"Hyponatremia in critically ill patients","volume":"18","author":"Vachharajani","year":"2003","journal-title":"J. Intensive Care Med."},{"key":"10.1016\/j.tem.2007.11.001_bib50","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/qjmed\/hci081","article-title":"Diagnostic approach to a patient with hyponatraemia: traditional versus physiology-based options","volume":"98","author":"Hoorn","year":"2005","journal-title":"QJM"},{"key":"10.1016\/j.tem.2007.11.001_bib51","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1542\/peds.113.5.1279","article-title":"Acute hyponatremia related to intravenous fluid administration in hospitalized children: an observational study","volume":"113","author":"Hoorn","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.tem.2007.11.001_bib52","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.3171\/foc.2004.16.4.11","article-title":"Syndrome of inappropriate secretion of antidiuretic hormone and hyponatremia after spinal surgery","volume":"16","author":"Amini","year":"2004","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.tem.2007.11.001_bib53","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00512052","article-title":"Cerebral salt wasting syndrome","volume":"19","author":"Uygun","year":"1996","journal-title":"Neurosurg. Rev."},{"key":"10.1016\/j.tem.2007.11.001_bib54","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11897-004-0008-5","article-title":"Vasopressin antagonists in heart failure","volume":"1","author":"Golestaneh","year":"2004","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.tem.2007.11.001_bib55","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","article-title":"Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials","volume":"297","author":"Gheorghiade","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2007.11.001_bib56","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2007.11.001_bib57","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2007.11.001_bib58","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1053\/gast.2003.50143","article-title":"Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial","volume":"124","author":"Gerbes","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tem.2007.11.001_bib59","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1210\/jcem-33-2-254","article-title":"Radioimmunoassay of arginine vasopressin in human plasma","volume":"33","author":"Beardwell","year":"1971","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2007.11.001_bib60","doi-asserted-by":"crossref","first-page":"I129","DOI":"10.1161\/01.HYP.5.2_Pt_2.I129","article-title":"Plasma and platelet vasopressin in essential hypertension and congestive heart failure","volume":"5","author":"Preibisz","year":"1983","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2007.11.001_bib61","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/clinchem\/45.1.98","article-title":"Improved extraction procedure and RIA for determination of arginine8-vasopressin in plasma: role of premeasurement sample treatment and reference values in children","volume":"45","author":"Kluge","year":"1999","journal-title":"Clin. Chem."},{"key":"10.1016\/j.tem.2007.11.001_bib62","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI108377","article-title":"Distribution, blood transport, and degradation of antidiuretic hormone in man","volume":"57","author":"Baumann","year":"1976","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2007.11.001_bib63","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1172\/JCI107423","article-title":"Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma","volume":"52","author":"Robertson","year":"1973","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2007.11.001_bib64","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1385\/JMN:18:3:223","article-title":"Dynamic processing of neuropeptides: sequential conformation shaping of neurohypophysial preprohormones during intraneuronal secretory transport","volume":"18","author":"Acher","year":"2002","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.tem.2007.11.001_bib65","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1210\/jc.82.1.51","article-title":"Heterogeneity in clinical manifestation of autosomal dominant neurohypophyseal diabetes insipidus caused by a mutation encoding Ala-1\u2192Val in the signal peptide of the arginine vasopressin\/neurophysin II\/copeptin precursor","volume":"82","author":"Repaske","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2007.11.001_bib66","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0006-291X(88)90625-0","article-title":"The glycopeptide moiety of vasopressin-neurophysin precursor is neurohypophysial prolactin releasing factor","volume":"151","author":"Nagy","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tem.2007.11.001_bib67","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1210\/endo-125-1-35","article-title":"The vasopressin-associated glycopeptide is not a prolactin-releasing factor: studies with lactating Brattleboro rats","volume":"125","author":"Hyde","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2007.11.001_bib68","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.1021\/bi0400094","article-title":"Properties of human vasopressin precursor constructs: inefficient monomer folding in the absence of copeptin as a potential contributor to diabetes insipidus","volume":"43","author":"Barat","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.tem.2007.11.001_bib69","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev.biochem.69.1.69","article-title":"Protein glucosylation and its role in protein folding","volume":"69","author":"Parodi","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.tem.2007.11.001_bib70","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0968-0004(02)00004-X","article-title":"Lectin control of protein folding and sorting in the secretory pathway","volume":"28","author":"Schrag","year":"2003","journal-title":"Trends Biochem. Sci."}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276008000027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276008000027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T10:20:43Z","timestamp":1588587643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276008000027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S1043276008000027"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2007.11.001","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}